Breakthrough study halts growth of prostate cancer in the lab

An Agency study engineered a molecule that blocked the growth of prostate cancer and shrank the size of the tumour. This sets the stage for the development of innovative approaches to treat androgen-independent prostate cancer — the advanced stage of the disease for which there is no cure.

$95 Million cancer research centre opens

The Agency’s new $95 million, Research Centre, funded partly by BC Cancer Foundation donors, opened in Vancouver. It received Canada’s first LEED Gold designation for a medical facility and has become a symbol and icon for its groundbreaking translational research output.

Protein may help understand link between infection and cancer

Researchers published findings in the journal Immunity about the activity of a protein, SHIP, which regulates how we respond to microbial infections and inflammation-inducing agents. This research has implications for cancer control and increases our understanding of allergies and autoimmune disorders such as asthma. It could play an important role in controlling septic shock in hospital patients.

Pages